People · Operator
Named in public records as an officer, director or promoter · active 2006–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Serina Therapeutics, Inc. | — | Biotechnology | Series A | $46.4M | $98.2M | 2006 |
| EGEN, Inc. | — | Biotechnology | Series A | $18.4M | $141.6M | 2008 |
Lonnie S McMillian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lonnie S McMillian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| J Milton Harris | 2 | 2 |
| Robert S Langer | 1 | 14 |
| James R. Hudson, Jr. | 1 | 3 |
| Khursheed Anwer | 1 | 2 |
| Michael D Bentley | 1 | 1 |
| Tacey R Viegas | 1 | 1 |
| Barbara Milton Fisk | 1 | 1 |
| Barbara M Fisk | 1 | 1 |
| Steve H Ledger | 1 | 1 |
| Greg H Bailey, M.D. | 1 | 1 |
| Miguel A Loya | 1 | 1 |
| Brendan A Rae | 1 | 1 |
| Danny H Lewis | 1 | 1 |
| Sung Wan Kim | 1 | 1 |
| Randall W Moreadith | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.